Connect with us

News

‘Bloodbath’: Shock as Trump Fires Thousands at HHS Amid Measles and Bird Flu Outbreaks

Published

on

The United States is reportedly on pace for its worst year of measles infections this century, with 483 confirmed measles cases across 20 states. At the same time, 70 human cases of bird flu have been identified in 13 states. As these outbreaks of potentially deadly diseases escalate, with no clear resolution in sight, the Trump administration has begun the process of firing an estimated 10,000 to 20,000 employees at the U.S. Department of Health and Human Services.

Amid the ongoing bird flu outbreak, the “top FDA veterinarian working to help the Trump administration fight bird flu has been let go,” according to Wall Street Journal health reporter Liz Essley Whyte.

Medical and public health experts are in shock and sounding the alarm.

“The FDA as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of product development and safety no longer employed,” remarked Dr. Robert Califf, who served twice as Commissioner of the Food and Drug Administration, under presidents Obama and Biden. He calls this “a dark day for public health” that history will see as “a huge mistake.”

READ MORE: Trump Team Eyes Emergency Plan to Offset Tariff ‘Financial Devastation’ for Farmers: NYT

Dr. Califf says he is now hearing that firms are preparing to move research and development to Europe and China. He added, “maybe there’s a plan to nurture the profound advances in medicine & tech on the horizon rather than promote unproven remedies like cod liver oil and supplements for serious diseases.”

The Washington Post points to the “purge of leadership” at the U.S. health agencies that make up HHS. They include the Centers for Disease Control and Prevention (CDC), Centers for Medicare & Medicaid Services (CMS), Food and Drug Administration (FDA), Health Resources and Services Administration (HRSA), National Institutes of Health (NIH), among others.

“At the National Institutes of Health, a nearly $48 billion biomedical research agency, at least five top leaders were put on leave,” according to the Post. “Among those offered reassignment were the infectious-disease institute director Jeanne Marrazzo,” who “had succeeded Anthony S. Fauci as director of the National Institute of Allergy and Infectious Diseases, an institute that helped lead the nation’s response to the coronavirus pandemic and that later became a target of Republicans.”

Sam Stein at The Bulwark calls Tuesday’s firings a “bloodbath,” and a “mass culling.”

“Multiple officials who work in the department told The Bulwark that entire offices were being eliminated, the conservative media outlet reported. “To get a fuller sense of the despair, head over to the NIH’s Reddit forum; or the HHS forum. It’s bleak. That’s what happens, we suppose, when a weeks-old administration decides that it will eliminate 10,000 full-time employees from one of its most critical departments.”

READ MORE: ‘We’re Gonna Boom’: Trump Mocks Wall Street’s Stagflation Predictions Despite Grim Data

“Generation of scientists, health care officials being wiped out,” Stein wrote on social media.

Dr. Rob Davidson, executive director of the nonprofit Committee to Protect Health Care wrote: “Slashing 20,000 HHS jobs is reckless. Pairing that with Medicaid cuts? That’s not reform—it’s sabotage. You don’t ‘fix’ healthcare by gutting its core. People will suffer.”

Claiming “streamlining,” and “efficiency,” HHS Secretary Robert F. Kennedy Jr. announced the layoffs late last week, declaring he “will eliminate an entire alphabet soup of departments, while preserving their core functions by merging them into a new organization called the Administration for a Healthy America or AHA. This overhaul will improve the health of the entire nation — to Make America Healthy Again.”

Dr. Craig Spencer, an emergency room physician who treated Ebola patients and subsequently contracted the often deadly disease but survived, blasted the firings.

“Thousands of the best experts at FDA, NIH, and all across HHS are being terminated right now,” Dr. Spencer wrote. “These are the people who make sure the medications you and your children take are safe. These are the people who perform and oversee research on cancer, infant health, and so so so much more. These are the people who make sure new devices that physicians and patients use are effective. These are the people who keep workers safe on the job and help prevent devastating injuries for workers all around the country. These are the people who track what drugs and medications are experiencing shortages so we can adapt. These are the people who help tackle HIV and other infectious diseases, asthma, lead poisoning, and everything else that makes many Americans sick. And now, thousands of them are gone. There is no way this makes Americans healthier. We will regret this.”

STAT News reports that about twenty-five percent of the entire HHS workforce is expected to be eliminated:

“As of last week, it was estimated that the FDA would take the biggest cut, losing roughly 3,500 employees, or about 19% its workforce, followed by the Centers for Disease Control and Prevention, which was expected to lose … about 18% of its staff. The National Institutes of Health was projected to lose about 1,200 employees, or about 6% of its workers.”

Dr. Scott Gottlieb, who served as FDA Commissioner during President Donald Trump’s first administration, did not appear to directly address the firings, but chose the day they are happening to warn about the destruction of the ecosystem that works to create new drugs, which includes HHS agencies like the FDA and the NIH.

“Twenty-five years ago, it was common to hear complaints about a ‘drug lag’—the perception that Europeans routinely enjoyed medical advances years before their American counterparts. Through a generation of congressional actions, investments in expertise and hiring, and careful policymaking, we built the FDA into the most efficient, forward-leaning drug regulatory agency in the world—and established the U.S. as the global center of biopharmaceutical innovation. Today, the cumulative barrage on that drug-discovery enterprise, threatens to swiftly bring back those frustrating delays for American consumers, particularly affecting rare diseases and areas of significant unmet medical need.”

READ MORE: ‘Even the Rich Are Worried’: Experts Warn of ‘Scariest’ Signs Amid ‘Stagflation’ Fears

 

Image via Reuters

 

There's a reason 10,000 people subscribe to NCRM. You can get the news before it breaks just by subscribing, plus you can learn something new every day.
Continue Reading
Click to comment
 
 

Enjoy this piece?

… then let us make a small request. The New Civil Rights Movement depends on readers like you to meet our ongoing expenses and continue producing quality progressive journalism. Three Silicon Valley giants consume 70 percent of all online advertising dollars, so we need your help to continue doing what we do.

NCRM is independent. You won’t find mainstream media bias here. From unflinching coverage of religious extremism, to spotlighting efforts to roll back our rights, NCRM continues to speak truth to power. America needs independent voices like NCRM to be sure no one is forgotten.

Every reader contribution, whatever the amount, makes a tremendous difference. Help ensure NCRM remains independent long into the future. Support progressive journalism with a one-time contribution to NCRM, or click here to become a subscriber. Thank you. Click here to donate by check.

News

‘New MAGA Slush Fund’ Could Hand Trump Coalition ‘Cut of the Spoils’: Columnist

Published

on

President Donald Trump reportedly may drop his $10 billion lawsuit against the IRS in a settlement handing him control of a $1.7 billion “MAGA slush fund” to compensate victims of government abuse, according to The New Republic‘s Greg Sargent, who calls it a “Shakedown.”

Citing an ABC News report, Sargent explains that the proposed settlement “would create a ‘commission’ with ‘total authority’ to settle ‘claims’ brought by those who allege such weaponization. Per ABC, this not only includes the insurrectionists; it could even settle purported claims by ‘entities associated with President Trump himself.’ By all indications it would operate with little-to-no congressional oversight.”

U.S. Rep. Jamie Raskin (D-MD) told Sargent it is “a shocking new betrayal of the Constitution.”

This “new MAGA slush fund,” Sargent says, would come from an existing Justice Department fund that has strict controls, including transparency requirements. But “Trump would wield quasi-direct control” over the $1.7 billion, including being able to fire commission members “without cause,” and “it wouldn’t be required to disclose its decision-making involving who gets awarded compensation.”

Raskin told Sargent, the “Judgment Fund exists to settle valid judgments against the United States government.”

Raskin said that Trump and his allies are “trying to take money from the Judgment Fund while eliminating any controls and oversight” and put it under Trump’s “direct unilateral control.”

Because Congress did not set up any fund like this it could be unconstitutional.

“Congress never would have passed a $1.7 billion slush fund for his friends—this is completely outside of our constitutional framework,” Raskin said. He called it “an outrageous desecration of congressional power of the purse.”

Raskin also noted that the Constitution’s 14th Amendment prohibits government from assuming any “obligation incurred in aid of insurrection or rebellion against the United States.”

So if Trump wants to use the $1.7 billion to compensate the January 6 rioters, he will be “using federal taxpayer dollars to compensate people who participated in insurrection,” according to Raskin.

Trump and his lawyers “are figuring out a way to refund the January 6 militia, presumably to get them ready for the next round of battle,” Raskin said.

“So at bottom,” Sargent concludes, “payments from this fund might ultimately serve as a form of coalition management: They’ll keep large swaths of his coalition persuaded that a win for Trump, no matter how illicit or ill-gotten, is a win for them. That his corruption isn’t just in his own interests, but in theirs, too. Because, after all, they’re getting a cut of the spoils.”

 

Image via Shutterstock

Continue Reading

News

CNN Analyst Stunned Bottom Has ‘Completely Fallen Out’ For Trump

Published

on

CNN analyst Harry Enten is stunned at how far President Donald Trump’s approval rating has fallen, especially among Latino voters.

“The bottom has completely fallen out when it comes to Donald Trump and Latino voters,” Enten said on Friday.

“What a different world,” he exclaimed. “Oy vey, if I’m the president of the United States, because just take a look here.”

Trump won a “record share” of Latino voters for a “Republican presidential nominee, 46 percent of the vote,” Enten said, “going all the way back since we had the advent of exit polls back in 1972.”

Trump’s job approval rating, in an average of CNN polls, is 28 percent — “an 18 point drop,” Enten explained.

Latino voters from 2024 “have abandoned him with the utmost, just, dislike of what he is doing so far — just 28 percent, a drop of 18 points.”

And with Latino men, Enten said, “Oh, my goodness gracious.”

Trump is at -41 points, a “movement of 51 points, a shift away from the president of the United States.”

“Again, the bottom has just completely fallen out, and, of course, when you look across that political map, there are so many races that will be involving a lot of Latino voters, and when you see numbers like this, I just go, ‘Uh oh,’ if I am a Republican running for Congress,” he said.

Enten also said that one of the reasons Trump had “record performance with Latinos back in 2024, was because the issue of the economy. They trusted Donald Trump by a three-point margin against Kamala Harris.”

But his net approval on the economy now? “Minus 46 points.”

“No wonder the bottom has fallen out with Latino voters and Latino men in particular,” he added.

 

Image via Reuters 

Continue Reading

News

Alito Refuses to Recuse From Supreme Court Case Despite Stock Ownership in Industry

Published

on

Supreme Court Justice Samuel Alito is refusing to recuse himself from a major climate case despite owning stock in several energy companies, although none in the two that are parties in the lawsuit the court will hear next term.

Citing his energy stock ownership, liberal groups have been calling for the conservative justice to recuse, and they have asked the Senate Judiciary Committee to investigate Alito’s involvement, NBC News reports. But the Supreme Court says Alito is not obligated to do so.

“Justice Alito does not have a financial interest in any party” involved in the case, a court spokesperson told NBC News in a statement. The court’s legal counsel advised that “his recusal is not required.”

ExxonMobil and Suncor Energy are fighting to have dismissed a lawsuit involving damages for climate harms, NBC News reports.

Justices are not required to recuse unless they have a direct conflict, such as specific stock ownership, a personal relationship, or a history with the case prior to their appointment to the Supreme Court.

In their letter, the liberal groups say that justices should recuse if their “impartiality might reasonably be questioned” by an “unbiased and reasonable person who is aware of all relevant circumstances.”

The liberal groups also say they have “deep concerns” about Alito’s “inconsistent history of recusals from cases from which he should be compelled to recuse under long-standing federal law.” They cite “his substantial holdings in individual oil and gas companies and other personal ties.”

They point to what they call Alito’s “irregular recusal practice in oil and gas industry-related cases,” saying that it is “undermining public confidence in the impartiality of the Court.”

NBC notes that “in 2023, Alito did recuse himself when the court turned away an appeal from the companies in the Colorado case.” That same day, “the court rejected appeals in similar cases involving other companies, including ConocoPhillips and Phillips 66. Alito also did not participate in those cases.”

But the court’s spokesperson said that Alito was “inadvertently recused” from the Colorado case.

 

Image via Reuters 

 

Continue Reading

Trending

Copyright © 2026 AlterNet Media.